Lethargy: Clinical Trials

2 trials for Lethargy, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 unknown. 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 22Unknown 2

Follow Lethargy: new trials by email Literature Review of Lethargy trials Research Report on Lethargy

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Intranasal Oxytocin for Frontotemporal Dementia
Syntocinon - Frontotemporal Dementia
Phase 2UnknownLondon Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's1122018-01-312023-12-15
Repetitive Transcranial Magnetic Stimulation for Apathy Treatment in Alzheimer's Disease
Magnetic Stimulator Magstim Rapid 2, Sham Magnetic Stimulator - Alzheimer's Disease, Apathy
Phase 2UnknownFederal University of Minas Gerais402013-06-012013-06-25

Narrower conditions

Alzheimer Disease (1)  ·  Frontotemporal Dementia (1)

Broader conditions

Brain Diseases (2)  ·  Central Nervous System Diseases (2)  ·  Dementia (2)  ·  Mental Disorders (2)  ·  Nervous System Diseases (2)  ·  Neurobehavioral Manifestations (2)  ·  Neurocognitive Disorders (2)  ·  Neurodegenerative Diseases (2)  ·  Neurologic Manifestations (2)  ·  Pathological Conditions, Signs and Symptoms (2)  ·  Signs and Symptoms (2)  ·  Frontotemporal Lobar Degeneration (1)  ·  Metabolic Diseases (1)  ·  Nutritional and Metabolic Diseases (1)  ·  Proteostasis Deficiencies (1)

Interventions

Oxytocin (1)

Sponsors

Federal University of Minas Gerais (1)  ·  London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's (1)

Countries

Brazil (1)  ·  Canada (1)  ·  United States (1)

Top investigators

Breno S Diniz, MD, PhD (1)

Results publications

PMID 30261917, PMID 39862881